Best Peptides for Melasma

Melasma is a common condition characterized by symmetric patches of hyperpigmentation, typically appearing on the face and often triggered or exacerbated by hormonal factors, UV exposure, and genetic predisposition. Research into peptide interventions for melasma remains limited, though studies have explored peptides that may influence melanin production and skin barrier function, including alpha-MSH (alpha-melanocyte-stimulating hormone) analogs and copper peptides, which are being investigated for their potential effects on melanogenesis and skin remodeling rather than direct depigmentation.

Peptide research for melasma typically involves topical application protocols rather than systemic dosing, with study durations ranging from 8-12 weeks to assess changes in pigmentation. Timing and concentration vary significantly across research models, and practical application often requires consistency with sun protection measures, as UV exposure remains a primary driver of melasma progression.